Editorial Advisory Board

The Editorial Advisory Board of Dissolution Technologies is a distinguished group of scientists active in fields and/or organizations related to dissolution testing. Members of the board review manuscripts and suggest subject matters relevant to dissolution testing.

CYNTHIA K. BROWN
Editorial Advisory Board Chair
Eli Lilly and Company

WILLIAM BROWN
USP

ROBERT G. BUICE, Ph.D.
Buice & Associates, LLC

BRYAN CRIST
Agilent Technologies

DR. JENNIFER B. DRESSMAN
Johann Wolfgang Goethe - Universität
Frankfurt am Main, Germany

NIKOLETTA FOTAKI, Ph.D.
University of Bath, Bath, UK

VIVIAN A. GRAY
V.A. Gray Consulting, Inc.

SANDRA KLEIN, Ph.D.
Ernst Moritz Arndt University of Greifswald

JOHANNES KRÄMER, Ph.D.
PHAST

RAIMAR LÖBENBERG, Ph.D.
University of Alberta

PETRA LOOS, Ph.D.
Sanofi-Aventis

XUJIN LU, Ph. D.
Bristol-Myers Squibb

MARGARETH R. C. MARQUES, Ph.D.
USP

GREGORY P. MARTIN
Complectors Consulting

JOHN W. MAUGER, Ph.D.
University of Utah

ALEKSANDER MENDYK, Ph.D.
Jagiellonian University - Medical College, Cracow, Poland

RAKESH P. PATEL, Ph.D.
Ganpat University, Gujarat, India

JAMES E. POLLI, Ph.D.
University of Maryland

BRIAN R. ROHRS, Ph.D.
Bausch & Lomb

THOMAS W. ROSANSKE, Ph.D.
Beckloff Associates (a Cardinal Health Company)

PETER SCOTT
Dissolution Solutions

VINOD P. SHAH, Ph.D.
Pharmaceutical Consultant

DAVID C. SPERRY, Ph.D
Eli Lilly and Company

RODERICK B. WALKER, Ph. D.
Rhodes University, Grahamstown, South Africa